Literature DB >> 16045489

Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats.

Maulik D Jhaveri1, Steven J R Elmes, David A Kendall, Victoria Chapman.   

Abstract

The vanilloid TRPV1 receptor, present on primary afferent fibres, is activated by noxious heat, low pH and endogenous vanilloids. Changes in the function or distribution of TRPV1 receptors may play an important role in pain induced by inflammation or neuropathy. The aim of the present study was to evaluate the role of peripheral TRPV1 receptors in thermal nociception in rat models of inflammatory and neuropathic pain. Here, we have determined the effects of peripheral administration of the potent TRPV1 receptor antagonist iodoresiniferatoxin (IRTX) on noxious heat (45 degrees C)-evoked responses of spinal wide dynamic range (WDR) neurons in naïve, carrageenan-inflamed, sham-operated and L5/6 spinal nerve-ligated (SNL) anaesthetized rats in vivo. In addition, effects of peripheral administration of IRTX on mechanically evoked responses of WDR neurons were determined in sham-operated and SNL rats. Carrageenan inflammation significantly (P<0.05) increased the 45 degrees C-evoked responses of WDR neurons. Intraplantar injection of the lower dose of IRTX (0.004 microg) inhibited (P<0.05) 45 degrees C-evoked responses of WDR neurons in carrageenan-inflamed, but not in naïve, rats. The higher dose of IRTX (0.4 microg) significantly (P<0.05) inhibited 45 degrees C-evoked responses in both inflamed and naïve rats. In sham-operated and SNL rats, IRTX (0.004 and 0.4 microg) significantly (P<0.05) inhibited 45 degrees C-evoked, but had no effect on mechanically evoked responses of WDR neurons. These data support the role of peripheral TRPV1 receptors in noxious thermal transmission in naïve, inflamed and neuropathic rats, and suggest that there is an increased functional contribution of peripheral TRPV1 receptors following acute inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045489     DOI: 10.1111/j.1460-9568.2005.04227.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

Review 1.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

2.  2020 Foresight: Envisioning Therapeutic Innovations for Pain.

Authors:  May Hamza; Raymond A Dionne
Journal:  Drug Discov Today Ther Strateg       Date:  2009

3.  LASSBio-881: an N-acylhydrazone transient receptor potential vanilloid subfamily type 1 antagonist orally effective against the hypernociception induced by capsaicin or partial sciatic ligation.

Authors:  J L M Tributino; M L H Santos; C M Mesquita; C K F Lima; L L Silva; R C Maia; C D Duarte; E J Barreiro; C A M Fraga; N G Castro; A L P Miranda; M Z P Guimaraes
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

Review 4.  TRPpathies.

Authors:  Kirill Kiselyov; Abigail Soyombo; Shmuel Muallem
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

Review 5.  TRP channels: potential drug target for neuropathic pain.

Authors:  Lovish Marwaha; Yashika Bansal; Raghunath Singh; Priyanka Saroj; Ranjana Bhandari; Anurag Kuhad
Journal:  Inflammopharmacology       Date:  2016-10-18       Impact factor: 4.473

6.  Antinociceptive and toxicological effects of Dioclea grandiflora seed pod in mice.

Authors:  Rita de Cássia da Silveira e Sá; Leandra Eugênia Gomes de Oliveira; Franklin Ferreira de Farias Nóbrega; Jnanabrata Bhattacharyya; Reinaldo Nóbrega de Almeida
Journal:  J Biomed Biotechnol       Date:  2010-03-25

7.  Antinociceptive Activity of Methanol Extract of Muntingia calabura Leaves and the Mechanisms of Action Involved.

Authors:  M H Mohd Sani; Z A Zakaria; T Balan; L K Teh; M Z Salleh
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-26       Impact factor: 2.629

8.  Acid solution is a suitable medium for introducing QX-314 into nociceptors through TRPV1 channels to produce sensory-specific analgesic effects.

Authors:  He Liu; Hong-Xing Zhang; Hui-Yan Hou; Xian-Fu Lu; Jing-Qiu Wei; Chun-Guang Wang; Li-Cai Zhang; Yin-Ming Zeng; Yong-Ping Wu; Jun-Li Cao
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

9.  Targeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain.

Authors:  Jialie Luo; Edgar T Walters; Susan M Carlton; Hongzhen Hu
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

10.  Coapplication of lidocaine and membrane-impermeable lidocaine derivative QX-222 produces divergent effects on evoked and spontaneous nociceptive behaviors in mice.

Authors:  Si-Ping Hu; Jing-Jing Zhao; Wei-Xing Wang; Yang Liu; He-Fen Wu; Chao Chen; Liang Yu; Jing-Bing Gui
Journal:  Biomed Res Int       Date:  2014-11-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.